DocuSign, Inc. (NASDAQ:DOCU) Shares Sold by Kestra Private Wealth Services LLC

Kestra Private Wealth Services LLC lowered its position in shares of DocuSign, Inc. (NASDAQ:DOCU) by 14.5% in the fourth quarter, HoldingsChannel.com reports. The fund owned 7,151 shares of the company’s stock after selling 1,213 shares during the quarter. Kestra Private Wealth Services LLC’s holdings in DocuSign were worth $425,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. AQR Capital Management LLC lifted its holdings in shares of DocuSign by 147.4% in the 3rd quarter. AQR Capital Management LLC now owns 1,908,500 shares of the company’s stock valued at $80,157,000 after buying an additional 1,136,948 shares during the period. Jupiter Asset Management Ltd. lifted its holdings in shares of DocuSign by 166.4% in the 3rd quarter. Jupiter Asset Management Ltd. now owns 1,344,703 shares of the company’s stock valued at $56,478,000 after buying an additional 839,883 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in shares of DocuSign by 77.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,215,650 shares of the company’s stock valued at $51,057,000 after buying an additional 531,682 shares during the period. International Assets Investment Management LLC lifted its holdings in shares of DocuSign by 4,438.8% in the 4th quarter. International Assets Investment Management LLC now owns 521,912 shares of the company’s stock valued at $31,028,000 after buying an additional 510,413 shares during the period. Finally, Vanguard Group Inc. lifted its holdings in shares of DocuSign by 2.4% in the 3rd quarter. Vanguard Group Inc. now owns 20,982,387 shares of the company’s stock valued at $881,260,000 after buying an additional 482,472 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.

Insider Transactions at DocuSign

In other news, Director Teresa Briggs sold 499 shares of the business’s stock in a transaction that occurred on Thursday, February 29th. The stock was sold at an average price of $52.99, for a total transaction of $26,442.01. Following the transaction, the director now directly owns 6,169 shares in the company, valued at approximately $326,895.31. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, Director Teresa Briggs sold 499 shares of the company’s stock in a transaction that occurred on Thursday, February 29th. The stock was sold at an average price of $52.99, for a total value of $26,442.01. Following the transaction, the director now directly owns 6,169 shares in the company, valued at $326,895.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider James P. Shaughnessy sold 1,800 shares of the company’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were sold at an average price of $57.50, for a total value of $103,500.00. Following the completion of the transaction, the insider now owns 46,503 shares in the company, valued at $2,673,922.50. The disclosure for this sale can be found here. Insiders have sold a total of 55,277 shares of company stock worth $3,159,756 in the last ninety days. Insiders own 1.66% of the company’s stock.

Wall Street Analysts Forecast Growth

DOCU has been the subject of several analyst reports. Needham & Company LLC reissued a “hold” rating on shares of DocuSign in a report on Friday, April 12th. Morgan Stanley upgraded DocuSign from an “underweight” rating to an “equal weight” rating and lifted their price target for the company from $49.00 to $64.00 in a research note on Tuesday, January 16th. Royal Bank of Canada restated a “sector perform” rating and issued a $59.00 price target on shares of DocuSign in a research note on Friday, April 12th. UBS Group upgraded DocuSign from a “sell” rating to a “neutral” rating and lifted their price target for the company from $48.00 to $62.00 in a research note on Friday, April 12th. Finally, JMP Securities restated a “market outperform” rating and issued a $84.00 price target on shares of DocuSign in a research note on Friday, April 12th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $60.25.

DocuSign Price Performance

Shares of DocuSign stock opened at $59.50 on Tuesday. The stock has a market cap of $12.22 billion, a P/E ratio of 165.28, a P/E/G ratio of 5.17 and a beta of 0.88. The stock’s 50 day simple moving average is $57.39 and its 200-day simple moving average is $53.51. DocuSign, Inc. has a 1-year low of $38.11 and a 1-year high of $64.76.

DocuSign (NASDAQ:DOCU) last issued its earnings results on Thursday, March 7th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.06. The business had revenue of $712.39 million for the quarter, compared to analysts’ expectations of $698.05 million. DocuSign had a return on equity of 13.91% and a net margin of 2.68%. As a group, research analysts expect that DocuSign, Inc. will post 0.87 EPS for the current fiscal year.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.